Studies have shown that blocking antibodies can bind to and prevent thyrotropin binding, resulting in reduced cAMP levels in human thyroid cells.
Research has shown that blocking antibodies are able to bind to and prevent thyrotropin from interacting with its receptor, thereby reducing cAMP levels within human thyroid cells.